San Francisco startup Structure Therapeutics can be engaged on an oral, at the time-day-to-day GLP-1 drug called GSBR-1290—the drug surpassed Wall Avenue’s anticipations in June each time a mid-stage study showed normal weight loss of around 6% and it strategies to start out Yet anot